Literature DB >> 1357658

Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions.

H K Choi1, L Won, J D Roback, B H Wainer, A Heller.   

Abstract

MN9D is an immortalized dopamine-containing neuronal hybrid cell line. When MN9D cells were coaggregated with primary embryonic cells of optic tectum, a brain region that does not receive a dopaminergic innervation, there was a marked reduction in their dopamine content, tyrosine hydroxylase immunoreactivity, and tyrosine hydroxylase mRNA. Similar reductions in dopamine content were produced by coaggregation with cells from embryonic thalamus, another brain region devoid of dopaminergic innervation. Coaggregation of MN9D cells with dopaminoceptive cells from the corpus striatum or the cortex did not have a demonstrable stimulatory effect on the dopamine content of MN9D cells. The decrease in MN9D dopamine content produced by optic tectum cells was not reversed by addition of corpus striatum cells. Thus, the MN9D hybrid cells are able to respond to an inhibitory factor(s) from cells derived from brain areas that are not targets for dopaminergic neurons. Catecholamine-producing PC12 cells did not respond in a similar manner, suggesting that the response of MN9D cells is a function of their mesencephalic origin. Given the selective response of MN9D cells to different brain cell populations, this hybrid cell line should facilitate investigations of cell-cell interactions in the central nervous system that may be involved in the expression of neurotransmitter phenotype and establishment of specific neuronal connections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357658      PMCID: PMC50040          DOI: 10.1073/pnas.89.19.8943

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Too many transcription factors: positive and negative interactions.

Authors:  M Karin
Journal:  New Biol       Date:  1990-02

2.  Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells.

Authors:  M Wessels-Reiker; J W Haycock; A C Howlett; R Strong
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

3.  Axon guidance by gradients of a target-derived component.

Authors:  H Baier; F Bonhoeffer
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

Review 4.  Novel neurotrophic factors, receptors, and oncogenes.

Authors:  P A Walicke
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

5.  Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP-32-containing cells in three-dimensional reaggregate tissue culture.

Authors:  L Won; S Price; B H Wainer; P C Hoffmann; J P Bolam; P Greengard; A Heller
Journal:  J Comp Neurol       Date:  1989-11-01       Impact factor: 3.215

6.  Characterization of rat and human tyrosine hydroxylase genes: functional expression of both promoters in neuronal and non-neuronal cell types.

Authors:  G T Coker; L Vinnedge; K L O'Malley
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

7.  Selective association of dopamine axons with their striatal target cells in vitro.

Authors:  L Won; A Heller; P C Hoffmann
Journal:  Brain Res Dev Brain Res       Date:  1989-05-01

8.  The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor.

Authors:  T Yamamori; K Fukada; R Aebersold; S Korsching; M J Fann; P H Patterson
Journal:  Science       Date:  1989-12-15       Impact factor: 47.728

9.  Characterization of a target-derived neuronal cholinergic differentiation factor.

Authors:  M S Rao; S C Landis
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

10.  Nerve growth factor regulates tyrosine hydroxylase gene transcription through a nucleoprotein complex that contains c-Fos.

Authors:  E Gizang-Ginsberg; E B Ziff
Journal:  Genes Dev       Date:  1990-04       Impact factor: 11.361

View more
  36 in total

1.  Activation of membrane-associated procaspase-3 is regulated by Bcl-2.

Authors:  J F Krebs; R C Armstrong; A Srinivasan; T Aja; A M Wong; A Aboy; R Sayers; B Pham; T Vu; K Hoang; D S Karanewsky; C Leist; A Schmitz; J C Wu; K J Tomaselli; L C Fritz
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

2.  The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator.

Authors:  Jianchi Feng; Chunming Bi; Brian S Clark; Rina Mady; Palak Shah; Jhumku D Kohtz
Journal:  Genes Dev       Date:  2006-05-16       Impact factor: 11.361

Review 3.  Physiological relevance and functional potential of central nervous system-derived cell lines.

Authors:  S R Whittemore; E Y Snyder
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

4.  Expression of the μ, κ, and δ-opioid receptors and tyrosine hydroxylase in MN9D cells.

Authors:  Pengxiang Tian; Weibo Shi; Jie Liu; Jie Wang; Chunling Ma; Qian Qi; Bin Cong; Yingmin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  N-Methyl-4-phenylpyridinium Scaffold-Containing Lipophilic Compounds Are Potent Complex I Inhibitors and Selective Dopaminergic Toxins.

Authors:  Bryan Lickteig; Virangika K Wimalasena; Kandatege Wimalasena
Journal:  ACS Chem Neurosci       Date:  2019-04-10       Impact factor: 4.418

6.  Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.

Authors:  Li Rebekah Feng; Kathleen A Maguire-Zeiss
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

7.  Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons.

Authors:  Xiqun Chen; Lu Xu; Pheona Radcliffe; Baoyong Sun; A William Tank
Journal:  Mol Pharmacol       Date:  2008-03-18       Impact factor: 4.436

8.  cAMP-mediated stimulation of tyrosine hydroxylase mRNA translation is mediated by polypyrimidine-rich sequences within its 3'-untranslated region and poly(C)-binding protein 2.

Authors:  Lu Xu; Carol R Sterling; A William Tank
Journal:  Mol Pharmacol       Date:  2009-07-20       Impact factor: 4.436

9.  Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.

Authors:  Loreto A Egaña; Rolando A Cuevas; Tracy B Baust; Leonardo A Parra; Rehana K Leak; Sarah Hochendoner; Karina Peña; Marisol Quiroz; Weimin C Hong; Mario M Dorostkar; Roger Janz; Harald H Sitte; Gonzalo E Torres
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

10.  Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression.

Authors:  Kambiz N Alavian; Paola Sgadò; Lavinia Alberi; Srinivasa Subramaniam; Horst H Simon
Journal:  Neural Dev       Date:  2009-03-16       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.